
AstraZeneca Explores $400 Billion Merger With Pharmaceutical Rival Bristol Myers Squibb
AstraZeneca is in talks with Bristol Myers Squibb (BMS) over a potential merger that would create one of the world’s

AstraZeneca is in talks with Bristol Myers Squibb (BMS) over a potential merger that would create one of the world’s






Get notified about new articles